Mosaic ImmunoEngineering, Inc.
CPMV
$0.67
$0.000.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.64% | -1.42% | -12.60% | -37.83% | -21.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.44% | -1.40% | -22.53% | -45.72% | -34.97% |
| Operating Income | 11.44% | 1.40% | 22.53% | 45.72% | 34.97% |
| Income Before Tax | 3.25% | -12.28% | 11.41% | 42.25% | 37.16% |
| Income Tax Expenses | -- | -100.00% | -- | -- | -- |
| Earnings from Continuing Operations | 3.25% | -10.52% | 11.41% | 41.44% | 37.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.25% | -10.52% | 11.41% | 41.44% | 37.16% |
| EBIT | 11.44% | 1.40% | 22.53% | 45.72% | 34.97% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 3.59% | -10.90% | 11.24% | 41.38% | 37.09% |
| Normalized Basic EPS | 3.82% | -12.31% | 11.18% | 42.13% | 36.69% |
| EPS Diluted | 3.59% | -19.41% | 11.24% | 41.38% | 37.09% |
| Normalized Diluted EPS | 3.82% | -12.31% | 11.18% | 42.13% | 36.69% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |